Medications for Hypogonadism

29 results

  • Azmiro (testosterone cypionate)

    (TESTOSTERONE CYPIONATE)
    Azurity Pharmaceuticals, Inc.
    Usage: AZMIRO is indicated for testosterone replacement therapy in males with conditions causing testosterone deficiency, including primary hypogonadism (e.g., testicular failure, Klinefelter’s syndrome) and hypogonadotropic hypogonadism (e.g., pituitary-hypothalamic injury). The safety and efficacy for age-related hypogonadism and pediatric patients under 12 are not established.

  • Bromocriptine mesylate (bromocriptine mesylate)

    (Bromocriptine mesylate)
    Zydus Pharmaceuticals USA Inc.
    Usage: Bromocriptine mesylate capsules are indicated for treating hyperprolactinemia-related disorders (e.g., amenorrhea, infertility, hypogonadism), acromegaly, and symptoms of Parkinson's disease. It may be used with levodopa to enhance efficacy and reduce side effects, especially in patients experiencing tolerance or "end of dose failure."

  • Bromocriptine mesylate (bromocriptine mesylate)

    (Bromocriptine mesylate)
    Sandoz Inc
    Usage: Bromocriptine mesylate tablets are indicated for treating hyperprolactinemia-related dysfunctions (e.g., amenorrhea, infertility), acromegaly, and symptoms of Parkinson's disease. They help reduce tumor size in prolactin-secreting adenomas and enhance effects of levodopa in Parkinson's, while potentially reducing levodopa dosage and adverse reactions.

  • Climara (estradiol)

    (Estradiol)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from hypogonadism or primary ovarian failure, and for the prevention of postmenopausal osteoporosis, with specific limitations on its use for atrophy and osteoporosis.

  • Depo-testosterone (testosterone cypionate)

    (testosterone cypionate)
    Pharmacia and Upjohn Company LLC
    Usage: DEPO-Testosterone Injection is indicated for replacement therapy in men with testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., gonadotropin deficiency). Its safety and efficacy for "age-related hypogonadism" have not been established.

  • Estra-50 (estradiol pellet)

    (Estradiol pellet)
    Advanced Pharmaceutical Technology, Inc.
    Usage: Estradiol is indicated for treating estrogen deficiency in hysterectomized women, atrophic vaginitis, kraurosis vulvae, female hypogonadism, female castration, primary ovarian failure, and breast cancer (palliation only). It may also be used for postpartum breast engorgement, but risks must be assessed. Not effective during pregnancy.

  • Estradiol transdermal system (estradiol)

    (Estradiol)
    Sandoz Inc
    Usage: The Estradiol Transdermal System is indicated for treating moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from various causes, and prevention of postmenopausal osteoporosis, with specific limitations for certain conditions.

  • Kyzatrex (testosterone undecanoate)

    (TESTOSTERONE UNDECANOATE)
    Marius Pharmaceuticals
    Usage: KYZATREX™ is indicated for testosterone replacement therapy in adult males with testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., pituitary-hypothalamic injury). Safety and efficacy in males under 18 have not been established.

  • Methyltestosterone (methyltestosterone)

    (METHYLTESTOSTERONE)
    Amneal Pharmaceuticals of New York LLC
    Usage: Androgens are indicated for testosterone replacement therapy in males with primary and hypogonadotropic hypogonadism, and for stimulating puberty in selected cases. In females, they are used in treating advanced inoperable metastatic breast cancer post-menopause. Treatment decisions should involve expert judgment, especially in oncology.

  • Striant (testosterone)

    (testosterone)
    Columbia Laboratories, Inc.
    Usage: Striant® is indicated for replacement therapy in males with testosterone deficiency due to conditions like primary hypogonadism (testicular failure) and hypogonadotropic hypogonadism (gonadotropin or LHRH deficiency). It is used when serum testosterone levels are low, with varying gonadotropin levels.